We assessed cell-mediated immunity to herpes simplex virus type 1 antigen in patients suffering from recurrent cold sores and in a series of healthy controls. Paradoxically, all those subject to recurrent herpetic infections had, without exception, evidence of cell-mediated immunity to sponse to a preparation of herpes simplex antigen. In addition, intradermal skin tests with viral proteins were performed in some of the subjects.
Recurrent circumoral infection with herpes simplex virus (HSV) is virtually confined to people who have demonstrable serum-neutralizing antibodies to the virus (2, 34) . This inconsistency with previous ideas of virus-host interaction was first commented upon by Andrewes and Carmichael in 1930 (2) . We have recently added to this paradox by demonstrating that all such patients can also be shown to have cell-mediated immunity (CMI) to HSV antigens (36, 37) ; submitted for publication. Since the techniques used (lymphocyte transformation and inhibition of leukocyte migration) are only indirect indexes of the cellmediated immune response, we have looked for more direct manifestations of CMI and examined the ability of mononuclear cells from patients with recurrent herpes simplex infections to kill virus-infected amnion cells. This may be a more reliable measure of CMI than lymphocyte transformation alone. Some of the antigens synthesized under the direction of viral deoxyribonucleic acid are expressed in the membrane of infected cells, and it is likely that these are more relevant in vivo than the several capsid proteins that were present in our initial viral extracts. There is thus less danger of examining the response to a functionally inappropriate antigen (22, 26, 39) . This technique depends on the release of 5'Cr from damaged target (i.e., amnion) cells after direct interaction with specifically sensitized mononuclear cells. Using blood from the same volunteers, we also examined lymphocyte stimulation in response to a preparation of herpes simplex antigen. In addition, intradermal skin tests with viral proteins were performed in some of the subjects.
MATERIALS AND METHODS
Volunteers were recruited from university students and staff and were divided into two groups: (i) those who were susceptible to circumoral herpes and had had at least two attacks in the previous year; and (ii) those who had never had any form of circumoral herpetic lesion. No volunteers were accepted if their history was uncertain or did not fit clearly into either of these two groups. None of the subjects had an active lesion at the time of testing.
HSV The interaction of humoral and cellular immunity in the absence of complement was studied. Dilutions of serum beginning with 0.1 ml of whole serum were added to the above incubation mixtures to assess (i) possible interference with the expression of cellular immunity by humoral factors, i.e., "blocking" antibodies, and (ii) an effect of antibody-mediated celldependent immune lysis by lymphocytes with receptors for the Fc portion of immunoglobulin (K cells) (12) .
The presence of complement-dependent serum antibodies reacting with membrane antigens from the infected cells was also assessed by the addition of 0.1 ml of fresh guinea pig complement and 0.1 ml of serum to the 0.025 ml of infected and control amnion cells as described by Smith et al. (39) .
Lymphocyte transformation in response to HSV antigen was carried out in the same group of patients, as previously described (36, 37) .
Complement fixation tests were used to assess serum antibodies to HSV (34) , and intradermal skin tests with HSV antigens were performed in 15 subjects in addition to those previously reported (34, 35) . A few patients had some induration in response to the control injection of uninfected tissue culture extract. The test was therefore read as positive only if the diameter of induration using the test antigen exceeded the control by 10 mm. Figure 1 . illustrates a typical curve relating the percentage of "Cr release to the effector/target cell ratio. All of the 13 patients with a clear history of recurrent cold sores had evidence of "Cr specific release after incubation of their effector mononuclear cells with infected HAE target cells (Tables 1 and 2 ). In addition, all had positive lymphocyte transformation, and those eight patients tested had positive skin tests as has been previously demonstrated (35) . Serum from these patients had complement-fixing antibodies to HSV antigens and would induce specific "Cr release from infected HAE cells in the presence of fresh -guinea pig complement (Tables 1 and 2 ), confirming that these antigens are expressed on the surface of the infected cells. In addition, these sera had the property of sensitizing the infected amnion cells to lysis by normal, nonimmune lymphocytes-so-called "K" cells (12) . The sera were very potent in this regard, and Fig. 2 shows the specific 5"Cr release when serial dilutions of two such sera were added to the infected amnion cells and the mixture was incubated with normal, nonsensitized lymphocytes. In this figure, the cells used were from normal volunteers (no. 18 and 23) and were shown in the same experiment not to induce specific "Cr release in the absence of serum from group 1 subjects (Table 1) . This antibody-mediated cell-dependent immune lysis effect could be demonstrated in all sera of group 1 subjects (herpes positive), but no blocking factors were found on any occasion. Those patients with recurrent infections who were skin tested all had a positive response. Apart closely with the results of lymphocyte proliferation and the skin tests and reinforce our earlier findings with these parameters (34, 35) .
RESULTS
Most people not suffering from recurrent herpes labialis do not show any immune response to the virus (Tables 1 and 2 ), but as found earlier there are a few exceptions (34, 35) . Some of these persons may be the asymptomatic virus carriers already described (18, 20) (Tables 1 and 2 ).
The herpesviruses have an unusual propensity to induce latent infections in humans, with clinical recurrences at intervals in some patients (11) . The form in which HSV remains latent is not known (33) . Nahmias and Roizman (25) have advocated the use of the term "recurrent infections" to include the asymptomatic viral reactivation that may occur (8, 18, 20) and used the term "recrudescent infection" to describe the recurrence of specific clinical lesions. Rasmussen et al. (30) have demonstrated that interferon production in vitro by patients' lymphocytes in response to HSV antigen wanes some weeks after a recrudescent infection. Lymphocyte transformation was essentially unchanged. This type of dissociation between the synthesis of various products of lymphocyte activation has already been described (6, 32) . It has also been suggested that this waning of the interferon response may account for the development of recrudescent infection (30) . Since the role of interferon in recovery from any virus infection is still uncertain (3, 37) and in experimental HSV infections in animals interferon would seem to play no part in the recovery process (7, 10, 17, 21, 27, 37, 38) 
